Sponsor

Federal University of Minas Gerais

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Federal University of Minas Gerais appears in 35 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials35
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

35 shown
Effect of Training and Use of Cane on Gait in Individuals With Parkinson's DiseaseNCT06950255 · lead sponsor · 2025-05-01
RECRUITING
Chronic Effect of FastingNCT03574103 · lead sponsor · 2018-07-09
RECRUITING
Effect of macaúba Oil Combined With Green ExercisesNCT07715461 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Deep Brain Stimulation in Parkinson's Disease: Motor and Functional OutcomesNCT07567599 · lead sponsor · 2026-06-02
ENROLLING_BY_INVITATION
Effects of Home-based High-speed Bodyweight Resistance Training in Individual With Parkinson's DiseaseNCT06646523 · lead sponsor · 2024-10-18
COMPLETED
Control of Hypertension and diAbetes in MINas GeraisNCT05660928 · lead sponsor · 2022-12-21
COMPLETED
High-Intensity Respiratory Muscle Training in Individuals With Parkinson's DiseaseNCT05608941 · lead sponsor · 2022-12-01
COMPLETED
Lactobacillus Helveticus in the Treatment of Major DepressionNCT04333277 · lead sponsor · 2020-04-01
UNKNOWN
Impact of Whey Protein Supplementation on Body Weight and Metabolic Parameters of Bariatric PatientsNCT04510389 · lead sponsor · 2019-03-01
COMPLETED
Nutritional Status and Pharmacological Treatment: Impact on the Toxicity and Quality of Life of Patients With Colorectal and Breast CancerNCT03759548 · lead sponsor · 2018-11-01
UNKNOWN
Online Platform for Healthy Weight Loss (POEmaS)NCT03435445 · lead sponsor · 2017-09-24
COMPLETED
Early Effect of Fasting on Metabolic, Inflammatory, and Behavioral Responses in Females With and Without ObesityNCT03532672 · lead sponsor · 2017-09-22
COMPLETED
Transnasal Endoscopy in Obese Patients Are Candidates for Bariatric SurgeryNCT03288259 · lead sponsor · 2016-12-01
UNKNOWN
Eating Behavior, Food Craving and Relation to Excessive Weight Gain in Patients Submitted to Liver TransplantationNCT03411616 · lead sponsor · 2016-08-23
COMPLETED
Effect of Gluten-free Diets on Anthropometric and Dietary Data of Healthy Eutrophic WomenNCT03129997 · lead sponsor · 2016-03-03
COMPLETED
Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.NCT02767206 · lead sponsor · 2016-03-01
UNKNOWN
Ginger Capsules for the Chronic Treatment of ObesityNCT02742194 · lead sponsor · 2015-08-01
UNKNOWN
Immunosuppression and Diet: the Role of Inflammation in the Adipose Tissue RemodelingNCT03103984 · lead sponsor · 2014-07-01
COMPLETED
Evaluation of the Educational Program of Diabetes Mellitus: Focus on EmpowermentNCT02132338 · lead sponsor · 2014-06-01
UNKNOWN
Effects of Gum Disease Treatment on Host Defense FactorsNCT03146975 · lead sponsor · 2014-03-02
COMPLETED
Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's DiseaseNCT01885806 · lead sponsor · 2013-06-01
UNKNOWN
Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.NCT03166566 · lead sponsor · 2011-03-01
COMPLETED
Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of TreatmentNCT02007291 · lead sponsor · 2009-06-01
COMPLETED
Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic PolymorphismsNCT03349320 · lead sponsor · 2009-06-01
COMPLETED
The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed DementiaNCT02187276 · lead sponsor · 2009-06-01
COMPLETED
Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and ComplicationsNCT01511094 · lead sponsor · 2009-06-01
UNKNOWN
Occupational Performance Problems in Individuals With Rheumatoid ArthritisNCT02968745 · lead sponsor · 2009-06-01
COMPLETED
Participation Restrictions in Rheumatoid ArthritisNCT02863653 · lead sponsor · 2009-06-01
COMPLETED
Activity Limitations in Rheumatoid ArthritisNCT02730286 · lead sponsor · 2009-06-01
COMPLETED
A Randomized Trial of Carvedilol in Chronic Chagas CardiomyopathyNCT01557140 · lead sponsor · 2003-05-01
COMPLETED
Periodontitis Treatment and Heart FailureNCT07036289 · collaborator · 2025-06-10
ACTIVE_NOT_RECRUITING
Metabolic Investigation, Physical Performance, Physical Training At Different Times of the Day in Obese WomenNCT06601660 · collaborator · 2024-09-16
UNKNOWN
Effects of an Exercise and Lifestyle Education Program for People With Diabetes and PrediabetesNCT03914924 · collaborator · 2020-01-20
UNKNOWN
Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx StudyNCT03572166 · collaborator · 2018-09-03
COMPLETED
Pulmonary Rehabilitation in Asthmatic PatientNCT02383069 · collaborator · 2015-02-01
COMPLETED

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Federal University of Minas Gerais as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor30
collaborator5
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.